Your browser doesn't support javascript.
loading
An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure for the quantification of carbamazepine-10,11-epoxide in human serum and plasma.
Schierscher, Tobias; Singh, Neeraj; Kobel, Anja; Wild, Janik; Bauland, Friederike; Geistanger, Andrea; Risch, Lorenz; Geletneky, Christian; Seger, Christoph; Taibon, Judith.
Afiliação
  • Schierscher T; 58117 Dr. Risch Ostschweiz AG , Buchs, Switzerland.
  • Singh N; 111618 Roche Diagnostics GmbH , Penzberg, Germany.
  • Kobel A; 58117 Dr. Risch Ostschweiz AG , Buchs, Switzerland.
  • Wild J; 58117 Dr. Risch Ostschweiz AG , Buchs, Switzerland.
  • Bauland F; 123305 Chrestos Concept GmbH & Co. KG , Essen, Germany.
  • Geistanger A; 111618 Roche Diagnostics GmbH , Penzberg, Germany.
  • Risch L; 58117 Dr. Risch Ostschweiz AG , Buchs, Switzerland.
  • Geletneky C; 111618 Roche Diagnostics GmbH , Penzberg, Germany.
  • Seger C; 58117 Dr. Risch Ostschweiz AG , Buchs, Switzerland.
  • Taibon J; 111618 Roche Diagnostics GmbH , Penzberg, Germany.
Clin Chem Lab Med ; 62(7): 1339-1351, 2024 Jun 25.
Article em En | MEDLINE | ID: mdl-38515344
ABSTRACT

OBJECTIVES:

A reference measurement procedure (RMP) using isotope dilution liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS) was developed and validated with the aim of accurately measuring carbamazepine-10,11-epoxide concentrations in human serum and plasma.

METHODS:

To establish traceability to SI units, the absolute content of the reference material was determined using quantitative nuclear magnetic resonance (qNMR) spectroscopy. As sample preparation a protein precipitation protocol followed by a high dilution step was established. Chromatographic separation from carbamazepine and potential metabolites was achieved using a C18 stationary phase. Selectivity, specificity, matrix effects, precision and accuracy, inter-laboratory equivalence, and uncertainty of measurement were evaluated based on guidelines from the Clinical and Laboratory Standards Institute, the International Conference on Harmonization, and the Guide to the Expression of Uncertainty in Measurement.

RESULTS:

The RMP demonstrated very good selectivity and specificity, showing no evidence of a matrix effect. This enabled accurate quantification of carbamazepine-epoxide in the concentration range of 0.0400-12.0 µg/mL. The intermediate precision was found to be less than 2.1 %, and the repeatability coefficient of variation (CV) ranged from 1.2 to 1.8 % across all concentration levels. Regarding accuracy, the relative mean bias varied from 1.4 to 2.5 % for native serum levels and from 1.4 to 3.5 % for Li-heparin plasma levels. The measurement uncertainty for single measurements ranged from 1.6 to 2.1 %.

CONCLUSIONS:

In this study, we introduce a new LC-MS/MS-based candidate RMP for accurately measuring carbamazepine-10,11-epoxide in human serum and plasma. This novel method offers a traceable and dependable platform, making it suitable for standardizing routine assays and assessing clinically relevant samples.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carbamazepina / Espectrometria de Massas em Tandem Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carbamazepina / Espectrometria de Massas em Tandem Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article